TKC106909
|
PANC-1 |
Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1; Panc-1-P |
17.0 |
% |
Activity |
C9120 |
|
TKC106909
|
MIA PaCa-2 |
MIA-PaCa-2; MIA-PACA-2; MIA-Pa-Ca-2; MIA Paca2; MIA PaCa2; MiaPaCa-2; MIAPACA-2; MiaPaca.2; MiaPaCa2; Miapaca2; MIAPaCa2; MIAPACA2; Mia PACA 2; MIAPaCa-2; PaCa2; MiaPaCa |
2.0 |
% |
Activity |
C9120 |
|
TKC106909
|
BXPC-3 |
BxPc-3; BXPC-3; Bx-PC3; BXPC3; BxPC3; BxPc3; Biopsy xenograft of Pancreatic Carcinoma line-3 |
7.0 |
% |
Activity |
C9120 |
|
TKC106909
|
CCRF-CEM |
CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C |
1990.0 |
nM |
GI50 |
C7953 |
Orphanet_99861 |
TKC106909
|
HL-60 |
HL 60; HL.60 HL60; Human Leukemia-60 |
1580.0 |
nM |
GI50 |
C9154 |
Orphanet_519 |
TKC106909
|
K562 |
K562; K.562; K 562; KO; GM05372; GM05372E |
2510.0 |
nM |
GI50 |
C9110 |
Orphanet_521 |
TKC106909
|
NCI-H522 |
NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 |
2510.0 |
nM |
GI50 |
C3512 |
|
TKC106909
|
SW-620 |
SW-620; SW 620; SW.620 |
3980.0 |
nM |
GI50 |
C4349 |
|
TKC106909
|
M14 |
M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 |
15800.0 |
nM |
GI50 |
C3802 |
|
TKC106909
|
MDA-MB-435 |
MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435 |
7940.0 |
nM |
GI50 |
C3802 |
|
TKC106909
|
IGROV-1 |
Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P |
19900.0 |
nM |
GI50 |
C7979 |
Orphanet_454723 |
TKC106909
|
ACHN |
|
15800.0 |
nM |
GI50 |
C6975 |
Orphanet_319298 |
TKC106909
|
CAKI-1 |
CAL 1; Centre Antoine Lacassagne-1 |
12500.0 |
nM |
GI50 |
C3224 |
|
TKC106909
|
TK-10 |
TK.10; TK 10; TK10 |
3160.0 |
nM |
GI50 |
C4033 |
Orphanet_319276 |
TKC106909
|
DU-145 |
DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 |
5010.0 |
nM |
GI50 |
C4863 |
|
TKC106909
|
MCF7 |
|
5010.0 |
nM |
GI50 |
C4194 |
|
TKC106909
|
T47D |
|
39800.0 |
nM |
GI50 |
C4194 |
|
TKC106909
|
MEC1 |
Mouse Epicardial Cells 1 |
5600.0 |
nM |
EC50 |
|
|